Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

The Lancet Neurology

Volumn 10, Issue 1, 2011, Pages 63-74

  Dalmau, Josep ^a   Lancaster, Eric ^a   Martinez Hernandez, Eugenia ^a   Rosenfeld, Myrna R ^a   Balice Gordon, Rita ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HALOPERIDOL; IMMUNOGLOBULIN; INFLUENZA VACCINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N METHYL D ASPARTATE RECEPTOR ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PENTOBARBITAL; PROPOFOL; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADD ON THERAPY; AMNESIA; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY TITER; AUTONOMIC DYSFUNCTION; BRAIN BIOPSY; BREATHING DISORDER; CANCER IMMUNOTHERAPY; CATATONIA; CAUCASIAN; CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMA; CONVALESCENCE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; ENCEPHALITIS; EPILEPTIC STATE; ETHNIC DIFFERENCE; GENE DISRUPTION; GENETIC ASSOCIATION; GROUPS BY AGE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INCIDENCE; INFLUENZA A (H1N1); LANGUAGE DISABILITY; MOLECULAR INTERACTION; MORTALITY; MULTIPLE CYCLE TREATMENT; NEGRO; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; OVARY TERATOMA; PHENOTYPE; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RELAPSE; REVIEW; RHABDOMYOLYSIS; SEIZURE; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS ENCEPHALITIS;

ALGORITHMS; ANTIBODIES; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MODELS, BIOLOGICAL; RECEPTORS, N-METHYL-D-ASPARTATE; RECOVERY OF FUNCTION;

EID: 78649995149     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70253-2     Document Type: Review

References (88)

1. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005, 58:594-604.
2. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
3. Pruss H, Dalmau J, Arolt V, Wandinger KP Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture. Nervenarzt 2010, 81:396. 398, 400, passim.
4. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009, 65:424-434.
5. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010, 9:67-76.
6. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010, 9:776-785.
7. Moscato EH, Jain A, Peng X, Hughes EG, Dalmau J, Balice-Gordon RJ Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 2010, published online Jul 14. 10.1111/j.1460-9568.2010.07349.
8. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
9. Varvat J, Lafond P, Page Y, Coudrot M, Reynaud-Salard M, Tardy B Acute psychiatric syndrome leading young patients to ICU: consider anti-NMDA-receptor antibodies. Anaesth Intensive Care 2010, 38:748-750.
10. Pruss H, Dalmau J, Harms L, et al. Retrospective analysis of anti-glutamate receptor (type NMDA) antibodies in patients with encephalitis of unknown origin. Neurology 2010, 75:1735-1739.
11. Davies G, Irani SR, Coltart C, et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 2010, 38:679-682.
12. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
13. Poloni C, Korff CM, Ricotti V, et al. Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-d-aspartate receptor encephalitis. Dev Med Child Neurol 2009, 52:e78-e82.
14. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, published online Oct 15. 10.1016/S1473-3099(10)70222-X.
15. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001, 124:1138-1148.
16. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
17. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008, 70:504-511.
18. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007, 3:291-296.
19. Ferioli S, Dalmau J, Kobet CA, Zhai QJ, Broderick JP, Espay AJ Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol 2010, 67:250-251.
20. Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008, 79:324-326.
21. Wong-Kisiel LC, Ji T, Renaud DL, et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis. Neurology 2010, 74:1550-1551.
22. Shimazaki H, Morita M, Nakano I, Dalmau J Inverse ocular bobbing in a patient with encephalitis associated with antibodies to the N-methyl-D-aspartate receptor. Arch Neurol 2008, 65:1251.
23. Labate A, Irani SR, Vincent A, et al. Anti-NMDA receptor encephalitis: a video case report. Epileptic Disord 2009, 11:267-269.
24. Bayreuther C, Bourg V, Dellamonica J, Borg M, Bernardin G, Thomas P Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord 2009, 11:261-265.
25. Weiner AL, Vieira L, McKay CA, Bayer MJ Ketamine abusers presenting to the emergency department: a case series. J Emerg Med 2000, 18:447-451.
26. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med 1981, 10:237-242.
27. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
28. Parratt KL, Allan M, Lewis SJ, Dalmau J, Halmagyi GM, Spies JM Acute psychiatric illness in a young woman: an unusual form of encephalitis. Med J Aust 2009, 191:284-286.
29. Kruer MC, Koch TK, Bourdette DN, et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology 2010, 74:1473-1475.
30. Kataoka H, Dalmau J, Taoka T, Ueno S Reduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis. Mov Disord 2009, 24:784-786.
31. Maeder-Ingvar M, Prior JO, Irani SR, Rey V, Vincent A, Rosetti AO FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry 2010, published online July 28. 10.1136/jnnp.2009.198697.
32. Pillai SC, Gill D, Webster R, Howman-Giles R, Dale RC Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol 2010, 43:217-220.
33. Llorens V, Gabilondo I, Gomez-Esteban JC, et al. Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA-receptor encephalitis. J Neurol 2010, 257:1568-1569.
34. Iizuka T, Yoshii S, Kan S, et al. Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 2010, published online Jun 2. 10.1007/s00415-010-5604-6.
35. Johnson N, Henry JC, Fessler AJ, Dalmau J Prolonged non-convulsive status epilepticus in anti-NMDAR encephalitis with ovarian teratoma. Neurology 2010, 75:1480-1482.
36. Camdessanche JP, Streichenberger N, Cavillon G, et al. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol 2010, published online Aug 16. 10.1111/j.1468-1331.2010.03180.
37. Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009, published online Aug 14. 10.1007/s00401-009-0582-4.
38. Lebas A, Husson B, Didelot A, Honnorat J, Tardieu M Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol 2010, 25:742-745.
39. Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology 2009, 73:2039-2040.
40. Poduval A, Antal Z, Lee T, Bar A, Dalmau J, Muzumdar R Immune-mediated encephalitis and virilization in association with a mature cystic ovarian teratoma in an adolescent girl. Horm Res 2009, 72:252-256.
41. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009, 28:1421-1429.
42. Baltagi SA, Shoykhet M, Felmet K, Kochanek PM, Bell MJ Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med 2010, 11:179-184.
43. Hofmann C, Baur MO, Schroten H Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence?. J Neurol 2010, published online Sep 30. 10.1007/s00415-010-5757-3.
44. Verhelst H, Verloo P, Dhondt K, et al. Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster. Eur J Paediatr Neurol 2010, published online Aug 5. 10.1016/j.ejpn.2010.07.004.
45. Wirtz PW, Bradshaw J, Wintzen AR, Verschuuren JJ Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families. J Neurol 2004, 251:1255-1259.
46. Wirtz PW, Willcox N, Roep BO, et al. HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma. Ann N Y Acad Sci 2003, 998:200-201.
47. Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 2002, 104:359-363.
48. Ishiura H, Matsuda S, Higashihara M, et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 2008, 71:1921-1923.
49. Braakman HM, Moers-Hornikx VM, Arts BM, Hupperts RM, Nicolai J Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010, 75:e44-e46.
50. Lee A, Glick DB, Dinwiddie SH Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J ECT 2006, 22:267-270.
51. Sabin TD, Jednacz JA, Staats PN Case records of the Massachusetts General Hospital. Case 26-2008. A 26-year-old woman with headache and behavioral changes. N Engl J Med 2008, 359:842-853.
52. Splinter WM, Eipe N Anti-NMDA receptor antibodies encephalitis. Paediatr Anaesth 2009, 19:911-913.
53. Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009, 66:704-709.
54. Kumar MA, Jain A, Dechant VE, et al. Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol 2010, 67:884-887.
55. Niehusmann P, Dalmau J, Rudlowski C, et al. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 2009, 66:458-464.
56. Rubio-Agustí I, Dalmau J, Sevilla T, Burgal M, Beltrán E, Bataller L. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord (in press).
57. Carroll BT The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr 2000, 5:26-33.
58. Iyer VN, Hoel R, Rabinstein AA Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009, 37:3024-3030.
59. Lewis P, Glaser CA Encephalitis. Pediatr Rev 2005, 26:353-363.
60. Nokura K, Yamamoto H, Okawara Y, Koga H, Osawa H, Sakai K Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 1997, 95:367-373.
61. Sebire G, Devictor D, Huault G, Aicardi J, Landrieu P, Tardieu M Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: an acute encephalopathy of obscure origin. J Pediatr 1992, 121:845-851.
62. Sebire G In search of lost time from "Demonic Possession" to anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2010, 67:141-142.
63. DeLong GR, Bean SC, Brown FR Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 1981, 38:191-194.
64. Hartley LM, Ng SY, Dale RC, Church AJ, Martinez A, de Sousa C Immune mediated chorea encephalopathy syndrome in childhood. Dev Med Child Neurol 2002, 44:273-277.
65. Haimi-Cohen Y, Soen G, Amir J, Kimia A, Varsano I Coma with abnormal movements and prolonged cognitive disturbances: a new subset of acute encephalopathy. Neuropediatrics 1996, 27:270-272.
66. Bernal F, Graus F, Pifarre A, Saiz A, Benyahia B, Ribalta T Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol (Berl) 2002, 103:509-515.
67. Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
68. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010, 30:5866-5875.
69. Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978, 298:1116-1122.
70. Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies. J Neurol 2010, published online July 24. 10.1007/s00415-010-5674-5.
71. Olney JW, Farber NB Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995, 52:998-1007.
72. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 1959, 81:363-369.
73. Bailey K Identification of a street drug as N-ethyl-1-phenylcyclohexylamine, a phencyclidine analog. J Pharm Sci 1978, 67:885-886.
74. Castellani S, Giannini AJ, Adams PM Physostigmine and haloperidol treatment of acute phencyclidine intoxication. Am J Psychiatry 1982, 139:508-510.
75. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
76. Haggerty GC, Forney RB, Johnson JM The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period. Toxicol Appl Pharmacol 1984, 75:444-453.
77. Jentsch JD, Roth RH The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
78. Chartoff EH, Heusner CL, Palmiter RD Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 2005, 30:1324-1333.
79. Mouri A, Noda Y, Noda A, et al. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mol Pharmacol 2007, 71:1598-1609.
80. Mohn AR, Gainetdinov RR, Caron MG, Koller BH Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
81. Belforte JE, Zsiros V, Sklar ER, et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010, 13:76-83.
82. Javitt DC, Zukin SR Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-1308.
83. Dutschmann M, Morschel M, Rybak IA, Dick TE Learning to breathe: control of the inspiratory-expiratory phase transition shifts from sensory- to central-dominated during postnatal development in rats. J Physiol 2009, 587:4931-4948.
84. Wu LJ, Zhuo M Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics 2009, 6:693-702.
85. Kleinig TJ, Thompson PD, Matar W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008, 23:1256-1261.
86. Florance-Ryan N, Dalmau J Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr 2010, 22:739-744.
87. The Medical Task Force on Anencephaly. N Engl J Med 1990, 322:669-674. The infant with anencephaly.
88. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135-1140.